The clinical significance of bcl-2 overexpression in breast cancer patients - A retrospective study with long term follow up
Date
2001Author
Bai, M. C.Agnantis, Niki J.
Zagorianakou, P.
Kamina, S.
Nonni, A. V.
![ORCID logo](https://orcid.org/sites/default/files/images/orcid_16x16.png)
Briassoulis, E. Ch
Source
Electronic Journal of Pathology and HistologyVolume
7Issue
1Pages
94-98Google Scholar check
Keyword(s):
Metadata
Show full item recordAbstract
We examined by immunohistochemistry the expression of the bcl-2 protein in sixty-eight cases of operated breast carcinoma patients (stage I, II and III) and correlated the findings with the prognosis. In 38.3% of the cases approximately all neoplastic cells were stained positive (complete expression). A strong impact of complete bcl-2 expression on the clinical outcome was identified (p=0.01). We consider this study as a new approach. There is evidence that the assessment of bcl-2 at the level of complete expression provides important prognostic information for breast carcinoma patients treated surgically.